Information, not a decision

Hodgkin lymphoma: tumour board sheet

Dated public registry data. It contains no treatment recommendation. 12 Nov 2026

Open trials (159)

NCT07519772	Phase 1/2	A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)	Recruiting
NCT06806033	Phase 2	Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL	Recruiting
NCT03618550	Phase 2	Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma	Recruiting
NCT07226843	Phase 1	A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers	Recruiting
NCT06150664	Phase 1	A Phase 1 of CTX-8371 in Patients With Advanced Malignancies	Recruiting
NCT06788509	Phase 1	A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring	By invitation only
NCT03125642	Phase 2	Auto Stem Cell Transplant for Lymphoma Patients	Recruiting
NCT07691606	Phase 1	A Study of ARC-02 in B-cell NHL	Recruiting
NCT03681561	Phase 1/2	Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma	Recruiting
NCT02727803	Phase 2	Personalized NK Cell Therapy in CBT	Recruiting
NCT02508038	Phase 1	Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors	Recruiting
NCT06059391	Phase 2	CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant	Recruiting

147 more in the doctor's list on the site.

No phase 3 trial in this list ended in the last 90 days.

Links only: read the guideline itself.

Made from the public data of Frontlight Research. Source: ClinicalTrials.gov. 12 Nov 2026

https://frontlightresearch.com/en/doctor/hodgkin-lymphoma/tumor-board